MDIs formulation [Regulatives / Guidelines]

posted by Mahesh M – India, 2014-12-12 07:57 (4212 d 16:18 ago) – Posting: # 14059
Views: 3,303

Hi ElMaestro,

Thanks for your responce.

❝ Especially when multiple inhalations are needed. A 30sec interval between any two inhalations adds some reassurance and is likely good for the efficacy.


do you have any reference for the same?


As you will see when you start the study 30secs is not a lot in practice.

We have to mention dosing procedure in protocol and if we not mention about 30 sec gap between two puffs, regulatory agency may ask for the same (means not follow the SPC with regards of dosing instruction)

please share your thoughts on that.

Regards

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
141 visitors (0 registered, 141 guests [including 28 identified bots]).
Forum time: 01:16 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5